AnteoTech Limited

Equities

ADO

AU000000ADO8

Biotechnology & Medical Research

Market Closed - Australian S.E. 02:10:45 2024-04-19 am EDT 5-day change 1st Jan Change
0.023 AUD +4.55% Intraday chart for AnteoTech Limited -4.17% -36.11%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Anteotech Seeks to Raise AU$6 Million From Share Placement; Shares Fall 26% MT
AnteoTech Receives AU$1.39 Million from Queensland Critical Minerals and Battery Technology Fund; Shares Down 3% MT
AnteoTech Settles Patent Claims for AU$300,000 MT
AnteoTech Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI
Anteotech Completes Construction of Anteo X Production Facility in Brisbane; Shares Climb 6% MT
AnteoTech Produces Anode Material Containing Proprietary Technology MT
AnteoTech Receives AU$3.8 Million R&D Tax Rebate; Shares Rise 3% MT
AnteoTech Limited(ASX:ADO) dropped from S&P Global BMI Index CI
AnteoTech Limited Reports Earnings Results for the Full Year Ended June 30, 2023 CI
AnteoTech Limited Announces Appointment of Mr. Andrew Cook as Company Secretary, Effective from 28 August 2023 CI
Anteotech Limited Announces Appointment of Mr. Andrew Cook as Chief Financial Officer CI
AnteoTech Halts Trade MT
AnteoTech Limited Announces Retirement of Christopher Parker from the Board of Directors CI
Anteotech to Undergo Major Rebranding; Shares Jump 10% MT
Anteotech Limited Announces Changes to Leadership Team CI
Anteotech Limited Announces Changes to Leadership Team CI
AnteoTech Limited(ASX:ADO) dropped from S&P/ASX Emerging Companies Index CI
AnteoTech Limited(ASX:ADO) dropped from S&P/ASX All Ordinaries Index CI
Anteotech, Wyon to Collaborate on Silicon Anodes for Micro-Batteries MT
Anteotech, Trinseo Europe Sign Deal to Develop New Product MT
AnteoTech Limited Reports Earnings Results for the Half Year Ended December 31, 2022 CI
AnteoTech Appoints Chief Marketing Officer MT
AnteoTech Limited Appoints Tsui Min Lian as Chief Marketing Officer, Effective 15 March 2023 CI
AnteoTech Receives AU$3.2 Million R&D Tax Refund MT
AnteoTech Ltd Announces Halt of European Rat Clinical Trial to Refocus Initiatives CI
Chart AnteoTech Limited
More charts
AnteoTech Limited is an Australia-based surface chemistry company. The principal activities of the Company consist of research, development and commercialization of technologies with surface management applications. The activities are primarily focused on the commercialization of these technologies across applications in the Life Science and Clean Energy Technology markets. Its lead product, AnteoX, provides significant improvement in anode performance and the Company has partnered with global suppliers in lithium-ion battery manufacturing. The life sciences division services the point of care and diagnostics markets from global diagnostics companies to technology developers. Its AnteoBind provides advantages in bioconjugation to rapidly speed up testing procedures and improve accuracy. It also offers bioconjugation and assay development services to assist point of care and diagnostics researchers and manufacturers in product development. It also offers ready-to-use kits.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ADO Stock
  4. News AnteoTech Limited
  5. Anteotech to Undergo Major Rebranding; Shares Jump 10%